有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(2R)-2-methyl-3-morpholin-4-ylpropyl]-2-phenylsulfanylacetamide | —— | C16H24N2O2S |
|
—— | N-[(2S)-2-methyl-3-morpholin-4-ylpropyl]-2-(4-methylphenyl)sulfanylacetamide | —— | C17H26N2O2S |
|
—— | N-[(2R)-2-methyl-3-morpholin-4-ylpropyl]-2-(4-methylphenyl)sulfanylacetamide | —— | C17H26N2O2S |
|
—— | (3S,5S)-3-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-5-methyloxolan-2-one | —— | C14H15N3O2S2 |
|
—— | (3R,5S)-3-[(4-cyclopropyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-5-methyloxolan-2-one | —— | C14H15N3O2S2 |
|
—— | N-[(2S)-1-methoxybutan-2-yl]-2-phenylsulfanylacetamide | —— | C13H19NO2S |
|
—— | N-[(2R)-1-methoxybutan-2-yl]-2-phenylsulfanylacetamide | —— | C13H19NO2S |
|
—— | N-[(2R)-1-methoxybutan-2-yl]-2-(4-methylphenyl)sulfanylacetamide | —— | C14H21NO2S |
|
—— | N-[(2S)-1-methoxybutan-2-yl]-2-(4-methylphenyl)sulfanylacetamide | —— | C14H21NO2S |
|
—— | N-[(3S)-1-methyl-6-oxopiperidin-3-yl]-2-phenylsulfanylacetamide | —— | C14H18N2O2S |
|
—— | 2-(2,4-dimethylphenyl)sulfanyl-N-[(2S)-1-methoxybutan-2-yl]pyridine-3-carboxamide | —— | C19H24N2O2S |
|
—— | N-[(3S)-1-methyl-6-oxopiperidin-3-yl]-2-(4-methylphenyl)sulfanylacetamide | —— | C15H20N2O2S |
|
—— | 2-(2,4-dimethylphenyl)sulfanyl-N-[(2R)-1-methoxybutan-2-yl]pyridine-3-carboxamide | —— | C19H24N2O2S |
|
—— | (2R,3S)-3-(2-cycloheptyloxyethylsulfonyl)butan-2-ol | —— | C13H26O4S |
|
—— | (2R,3R)-3-(2-cycloheptyloxyethylsulfonyl)butan-2-ol | —— | C13H26O4S |
|
—— | N-[(3R)-1-methyl-6-oxopiperidin-3-yl]-2-(4-methylphenyl)sulfanylacetamide | —— | C15H20N2O2S |
|
—— | (2S,3S)-3-(2-cycloheptyloxyethylsulfonyl)butan-2-ol | —— | C13H26O4S |
|
—— | N-[(3R)-1-methyl-6-oxopiperidin-3-yl]-2-phenylsulfanylacetamide | —— | C14H18N2O2S |
|
—— | 5-[(2R)-butan-2-yl]sulfanyl-1-(oxan-4-yl)tetrazole | —— | C10H18N4OS |
|
—— | (2S,3R)-3-(2-cycloheptyloxyethylsulfonyl)butan-2-ol | —— | C13H26O4S |
|
—— | 4-[5-[(2R)-butan-2-yl]sulfanyl-1,3,4-thiadiazol-2-yl]morpholine | —— | C10H17N3OS2 |
|
—— | 2-[3-[(2S)-butan-2-yl]sulfanyl-5-methyl-1,2,4-triazol-4-yl]acetamide | —— | C9H16N4OS |
|
—— | 2-[(2S)-butan-2-yl]sulfanyl-5-[(2-chloro-6-fluorophenyl)methyl]-1,3,4-oxadiazole | —— | C13H14ClFN2OS |
|
—— | 2-[(2R)-butan-2-yl]sulfanyl-5-[(3-fluorophenyl)methyl]-1,3,4-oxadiazole | —— | C13H15FN2OS |
|
—— | 2-[(2R)-butan-2-yl]sulfanyl-5-[(2-chloro-6-fluorophenyl)methyl]-1,3,4-oxadiazole | —— | C13H14ClFN2OS |
|
—— | N-[(2R)-1-(5-methylthiophen-2-yl)propan-2-yl]-2-phenylsulfanylacetamide | —— | C16H19NOS2 |
|
—— | 6-amino-1,3-dimethyl-5-[2-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylsulfanyl)acetyl]pyrimidine-2,4-dione | —— | C15H20N6O3S |
|
—— | 3-[5-[(2R)-butan-2-yl]sulfanyl-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]propanamide | —— | C14H24N4O2S |
|
—— | 5-[(2R)-butan-2-yl]sulfanyl-N,N-dimethyl-4-propan-2-yl-1,2,4-triazol-3-amine | —— | C11H22N4S |
|
—— | 2-[(2S)-butan-2-yl]sulfanyl-5-(2-chlorophenyl)-1,3,4-oxadiazole | —— | C12H13ClN2OS |
|
—— | 4-[5-[(2R)-butan-2-yl]sulfanyl-4-methyl-1,2,4-triazol-3-yl]morpholine | —— | C11H20N4OS |
|
—— | 3-[5-[(2S)-butan-2-yl]sulfanyl-4-[[(2R)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]propanamide | —— | C14H24N4O2S |
|
—— | (2S)-2-[(4-ethyl-5-oxo-1H-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S)-1-(4-fluorophenyl)ethyl]propanamide | —— | C15H19FN4O2S |
|
—— | 2-[(2S)-butan-2-yl]sulfanyl-5-[(3-fluorophenyl)methyl]-1,3,4-oxadiazole | —— | C13H15FN2OS |
|
—— | 2-[(2S)-butan-2-yl]sulfanyl-1-cyclopropylpyrimidin-4-one | —— | C11H16N2OS |
|
—— | 2-[(2R)-butan-2-yl]sulfanyl-5-(3-methylthiophen-2-yl)-1,3,4-oxadiazole | —— | C11H14N2OS2 |
|
—— | 2-[(2S)-butan-2-yl]sulfanyl-1-propan-2-ylpyrimidin-4-one | —— | C11H18N2OS |
|
—— | 3-[(2S)-butan-2-yl]sulfanyl-5-methyl-4-(2-thiophen-2-ylethyl)-1,2,4-triazole | —— | C13H19N3S2 |
|
—— | 2-[(2R)-butan-2-yl]sulfanyl-5-(2-chlorophenyl)-1,3,4-oxadiazole | —— | C12H13ClN2OS |
|
—— | 2-[(2R)-butan-2-yl]sulfanyl-5-(thiophen-2-ylmethyl)-1,3,4-oxadiazole | —— | C11H14N2OS2 |
|
—— | 3-[5-[(2R)-butan-2-yl]sulfanyl-4-[[(2S)-oxolan-2-yl]methyl]-1,2,4-triazol-3-yl]propanamide | —— | C14H24N4O2S |
|
—— | 3-[(2R)-butan-2-yl]sulfanyl-5-methyl-4-(2-thiophen-2-ylethyl)-1,2,4-triazole | —— | C13H19N3S2 |
|
—— | 2-(4-methylphenyl)sulfanyl-N-[(2S)-1-(5-methylthiophen-2-yl)propan-2-yl]acetamide | —— | C17H21NOS2 |
|
—— | 5-[(2S)-butan-2-yl]sulfanyl-N,N-dimethyl-4-propan-2-yl-1,2,4-triazol-3-amine | —— | C11H22N4S |
|
—— | 5-[(2R)-butan-2-yl]sulfanyl-N-(2,2,2-trifluoroethyl)-1,3,4-thiadiazol-2-amine | —— | C8H12F3N3S2 |
|
—— | 2-[(2S)-butan-2-yl]sulfanyl-5-(3-methylthiophen-2-yl)-1,3,4-oxadiazole | —— | C11H14N2OS2 |
|
—— | (3S,5S)-1-[5-[(2R)-butan-2-yl]sulfanyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]-3,5-dimethylpiperidine | —— | C18H28N4OS |
|
—— | N-[(2S)-1-(5-methylthiophen-2-yl)propan-2-yl]-2-phenylsulfanylacetamide | —— | C16H19NOS2 |
|
—— | 3-[(2S)-butan-2-yl]sulfanyl-4-methyl-5-propan-2-yl-1,2,4-triazole | —— | C10H19N3S |
|
—— | 3-[(2S)-butan-2-yl]sulfanyl-5-(thiophen-2-ylmethyl)-1H-1,2,4-triazole | —— | C11H15N3S2 |
|